Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of osteoradionecrosis with pentoxifylline and vitamin E (PENTO)
2015-000618-23Phase 2Completed
- Sponsor
- Region Västra Götaland
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of pentoxifylline and vitamin e in osteoradionecrosis (ORN) and osteonecrosis (2 arms), sponsored by Region Västra Götaland. Primary endpoint: Change in SH index (tissue and bone healing). Started Mar 2015; status: completed.
02
Drugs
pentoxifyllinevitamin e
03
Conditions
osteoradionecrosis (ORN)osteonecrosis
Beyond the preview
Go deeper on 2015-000618-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000618-23.